دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement
Chu X.a · Hong Y.a · Wang Y.a · Yu C.a · Wang L.a · Tong H.a · Yan J.a · Zhang Z.a · Xu G.a · Yao Y.a,b · Zeng R.a
doi : 10.1159/000519608
Am J Nephrol 2021;52:899–908
The role of plasma exchange in treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with severe kidney involvement is controversial. It is urgent to find effective treatments to improve prognosis of AAV patients. In this retrospective study, the outcomes of immunoadsorption (IA) onto protein A in AAV patients with severe kidney involvement were evaluated.
Dietary Omega-3 Fatty Acid Intake and Mortality in CKD Population: A 1999–2014 NHANES Analysis
Li W.-L.a · Zhang N.-H.b · Ge S.-W.a · Xu G.a
doi : 10.1159/000520027
Am J Nephrol 2021;52:909–918
High risk of early death, especially contributed to cardiovascular disease, exists in patients who have chronic kidney disease (CKD). And the burden of cardiovascular disease is able to be lightened by an increase in omega-3 polyunsaturated fatty acid (omega-3 PUFA). A diet high in omega-3 PUFA in the general population is protective, although it is inconclusive about its beneficial role in the CKD population.
Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013–2017
Paik J.M.a,b,c,d · Zhuo M.a,b,d,e · York C.a · Tsacogianis T.a · Kim S.C.a,d,f · Desai R.J.a,d
doi : 10.1159/000520028
Am J Nephrol 2021;52:919–928
The medication burden of patients with end-stage renal disease (ESRD) on hemodialysis, a patient population with a high comorbidity burden and complex care requirements, is among the highest of any of the chronic diseases. The goal of this study was to describe the medication burden and prescribing patterns in a contemporary cohort of patients with ESRD on hemodialysis in the USA.
Physical Exercise Improves Cognitive Function in Older Adults with Stage 3–4 Chronic Kidney Disease: A Randomized Controlled Trial
Otobe Y.a,b · Yamada M.c · Hiraki K.d · Onari S.a · Taki Y.e,f · Sumi H.e,f · Hachisuka R.e,f · Han W.e,f · Takahashi M.g · Suzuki M.b · Kimura Y.b,h · Koyama S.b · Masuda H.b · Shibagaki Y.f · Tominaga N.e,f
doi : 10.1159/000520230
Am J Nephrol 2021;52:929–939
Patients with chronic kidney disease (CKD) exhibit a higher probability of having cognitive impairment or dementia than those without CKD. The beneficial effects of physical exercise on cognitive function are known in the general older population, but more research is required in older adults with CKD.
Statin Use and Incidence of Chronic Kidney Disease in Hypercholesterolemia Patients with Normal Renal Function
You H.-S.a · Shin S.-J.b · Kim J.c · Kang H.-T.a,d
doi : 10.1159/000520532
Am J Nephrol 2021;52:940–948
Dyslipidemia is a known risk factor for chronic kidney disease (CKD). The effects of statins on CKD have already been studied in patients with CKD; however, data on the general population are limited. This study aimed to determine the relationship between statin use and the incidence of CKD in patients with hypercholesterolemia having normal renal function.
Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees
Diamantidis C.J.a,b,c · Zepel L.c,d · Wang V.a,c,e · Smith V.A.c,e · Hudson Scholle S.g · Tamayo L.f · Maciejewski M.L.a,c,e
doi : 10.1159/000519758
Am J Nephrol 2021;52:949–957
The prevalence of chronic kidney disease (CKD) in Medicare beneficiaries has quadrupled in the past 2 decades, but little is known about risk factors affecting the progression of CKD. This study aims to understand the progression in Medicare Advantage enrollees and whether it differs by provider recognition of CKD, race and ethnicity, or geographic location. In a large cohort of Medicare Advantage (MA) enrollees, we examined whether CKD progression, up to 5 years after study entry, differed by demographic and clinical factors and identified additional risk factors of CKD progression.
Can Understanding Outcomes for Medicare Advantage Enrollees Reduce Racial and Ethnic Disparities in Kidney Disease?
Norris K.C.
doi : 10.1159/000519759
Am J Nephrol 2021;52:958–960
Clinical Outcomes and Histological Patterns in Oxalate Nephropathy due to Enteric and Nonenteric Risk Factors
Reddy S.a · Bolen E.b · Abdelmalek M.a · Lieske J.C.c · Ryan M.d · Keddis M.T.a
doi : 10.1159/000520286
Am J Nephrol 2021;52:961–968
Current knowledge of risk factors and renal histologic patterns of oxalate nephropathy (ON) not due to primary hyperoxaluria (PH) has been limited to small case series and case reports. Thus, we analyzed and compared clinical risk factors, histologic characteristics, and renal outcomes of patients with biopsy-confirmed ON among a cohort of patients with enteric and nonenteric risk factors.
Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial
Ferreira J.P.a,b · Rossignol P.a · Bakris G.c · Mehta C.d · White W.B.e · Zannad F.a
doi : 10.1159/000519436
Am J Nephrol 2021;52:969–976
Worsening kidney function (WKF) is frequent among patients with type 2 diabetes (T2D) and a recent acute coronary syndrome (ACS) and is associated with a poor prognosis. An accurate prediction of WKF is clinically important.
Letter in Response to “HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety”
Yamamoto H.a · Nobori K.b · Matsuda Y.b · Hayashi Y.c · Hayasaki T.c · Akizawa T.d
doi : 10.1159/000520156
Am J Nephrol 2021;52:977–978
